Mark Yarema

1.3k total citations
41 papers, 842 citations indexed

About

Mark Yarema is a scholar working on Emergency Medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Yarema has authored 41 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Emergency Medicine, 21 papers in Pharmacology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Yarema's work include Poisoning and overdose treatments (23 papers), Drug-Induced Hepatotoxicity and Protection (19 papers) and Liver Disease and Transplantation (8 papers). Mark Yarema is often cited by papers focused on Poisoning and overdose treatments (23 papers), Drug-Induced Hepatotoxicity and Protection (19 papers) and Liver Disease and Transplantation (8 papers). Mark Yarema collaborates with scholars based in Canada, United States and Australia. Mark Yarema's co-authors include Charles E. Becker, Marco L.A. Sivilotti, David N. Juurlink, Steven C. Curry, David W. Johnson, Paul M. Wax, Charles Becker, Roy Purssell, Daniel A. Spyker and Margaret Thompson and has published in prestigious journals such as PEDIATRICS, Annals of Emergency Medicine and British Journal of Clinical Pharmacology.

In The Last Decade

Mark Yarema

41 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Yarema Canada 16 371 340 230 117 88 41 842
Suzanne Doyon United States 14 280 0.8× 156 0.5× 162 0.7× 44 0.4× 73 0.8× 22 610
Ilene B. Anderson United States 13 159 0.4× 182 0.5× 128 0.6× 29 0.2× 75 0.9× 20 695
Andrew R. Erdman United States 22 673 1.8× 235 0.7× 100 0.4× 33 0.3× 168 1.9× 23 1.2k
Gwenn Christianson United States 17 520 1.4× 187 0.6× 90 0.4× 32 0.3× 152 1.7× 20 964
Michael Hodgman United States 12 202 0.5× 363 1.1× 52 0.2× 49 0.4× 105 1.2× 18 692
Lisa L. Booze United States 17 529 1.4× 191 0.6× 91 0.4× 32 0.3× 157 1.8× 18 965
Ruben Thanacoody United Kingdom 14 326 0.9× 331 1.0× 36 0.2× 107 0.9× 54 0.6× 38 862
Angela L. Chiew Australia 17 388 1.0× 440 1.3× 34 0.1× 136 1.2× 53 0.6× 75 903
D R Jarvie United Kingdom 19 182 0.5× 212 0.6× 147 0.6× 54 0.5× 141 1.6× 37 913
Matthew H. Slawson United States 20 76 0.2× 264 0.8× 287 1.2× 81 0.7× 160 1.8× 35 1.2k

Countries citing papers authored by Mark Yarema

Since Specialization
Citations

This map shows the geographic impact of Mark Yarema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Yarema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Yarema more than expected).

Fields of papers citing papers by Mark Yarema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Yarema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Yarema. The network helps show where Mark Yarema may publish in the future.

Co-authorship network of co-authors of Mark Yarema

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Yarema. A scholar is included among the top collaborators of Mark Yarema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Yarema. Mark Yarema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sivilotti, Marco L.A., Mark Yarema, & David N. Juurlink. (2022). Treating acetaminophen overdose. Canadian Medical Association Journal. 194(15). E554–E554. 4 indexed citations
2.
Yarema, Mark, et al.. (2021). Massive Acetaminophen Overdose Treated Successfully with N-Acetylcysteine, Fomepizole, and Hemodialysis. Case Reports in Critical Care. 2021. 1–5. 6 indexed citations
3.
Chuang, Ryan, et al.. (2020). Outcomes After Recurrent Intentional Methanol Exposures Not Treated With Alcohol Dehydrogenase Inhibitors Or Hemodialysis. Journal of Emergency Medicine. 58(6). 910–916. 2 indexed citations
4.
Dong, Kathryn, Rhonda J. Rosychuk, Mark Yarema, et al.. (2019). Resident Physician Wellness Curriculum: A Study of Efficacy and Satisfaction. Cureus. 11(8). e5314–e5314. 12 indexed citations
5.
Yarema, Mark, Marco L.A. Sivilotti, David W. Johnson, et al.. (2018). Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning. Journal of Medical Toxicology. 14(2). 120–127. 37 indexed citations
6.
O’Gorman, Claire, et al.. (2017). Alberta’s provincial take-home naloxone program: A multi-sectoral and multi-jurisdictional response to overdose. Canadian Journal of Public Health. 108(4). 398–402. 10 indexed citations
7.
Ghosh, Sunita, et al.. (2017). PHArmacists’ perspective oN the Take hOme naloxone prograM (The PHANTOM Study). Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 150(4). 259–268. 6 indexed citations
8.
Yarema, Mark, Marco L.A. Sivilotti, David W. Johnson, et al.. (2016). Outcomes of Patients With Premature Discontinuation of the 21-h Intravenous N-Acetylcysteine Protocol After Acute Acetaminophen Overdose. Journal of Emergency Medicine. 50(4). 629–637. 8 indexed citations
9.
Ugarte-Torres, Alejandra, et al.. (2016). Lead Poisoning From a Ceramic Jug Presenting as Recurrent Abdominal Pain and Jaundice. ACG Case Reports Journal. 3(1). 141–143. 5 indexed citations
10.
Ruzycki, Shannon M. & Mark Yarema. (2016). Fentanyl misuse. Canadian Medical Association Journal. 188(9). 673–673. 2 indexed citations
11.
Dong, Kathryn, et al.. (2016). A cohort study of unstable overdose patients treated with intravenous lipid emulsion therapy. Canadian Journal of Emergency Medicine. 19(4). 256–264. 12 indexed citations
12.
Yarema, Mark, W. Martz, Roy Purssell, et al.. (2015). Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series. CMAJ Open. 3(1). E83–E90. 25 indexed citations
13.
Ruzycki, Shannon M., et al.. (2015). Intranasal Fentanyl Intoxication Leading to Diffuse Alveolar Hemorrhage. Journal of Medical Toxicology. 12(2). 185–188. 15 indexed citations
14.
Hall, Christine, et al.. (2014). “Bath salts” intoxication: a new recreational drug that presents with a familiar toxidrome. Canadian Journal of Emergency Medicine. 16(2). 171–176. 11 indexed citations
15.
Sivilotti, Marco L.A., et al.. (2010). Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clinical Toxicology. 48(8). 793–799. 41 indexed citations
16.
Yarema, Mark, David W. Johnson, R Berlin, et al.. (2009). Comparison of the 20-Hour Intravenous and 72-Hour Oral Acetylcysteine Protocols for the Treatment of Acute Acetaminophen Poisoning. Annals of Emergency Medicine. 54(4). 606–614. 74 indexed citations
17.
Ruha, Anne‐Michelle & Mark Yarema. (2006). Pharmacologic Treatment of Acute Pediatric Methamphetamine Toxicity. Pediatric Emergency Care. 22(12). 782–785. 18 indexed citations
18.
Yarema, Mark & Steven C. Curry. (2005). Envenomation by the Northern Blacktail Rattlesnake (Crotalus molossus molossus). Pediatric Emergency Care. 21(1). 40–42. 9 indexed citations
19.
Sivilotti, Marco L.A., et al.. (2005). A Risk Quantification Instrument for Acute Acetaminophen Overdose Patients Treated With N-Acetylcysteine. Annals of Emergency Medicine. 46(3). 263–271. 54 indexed citations
20.
Purssell, Roy, Mark Yarema, Ming Fang, et al.. (2004). Proportion of injured alcohol-impaired drivers subsequently convicted of an impaired driving criminal code offence in British Columbia. Canadian Journal of Emergency Medicine. 6(2). 80–88. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne Doyon Breakdown of academic impact, for papers by Ilene B. Anderson Breakdown of academic impact, for papers by Andrew R. Erdman Breakdown of academic impact, for papers by Gwenn Christianson Breakdown of academic impact, for papers by Michael Hodgman Breakdown of academic impact, for papers by Lisa L. Booze Breakdown of academic impact, for papers by Ruben Thanacoody Breakdown of academic impact, for papers by Angela L. Chiew Breakdown of academic impact, for papers by D R Jarvie Breakdown of academic impact, for papers by Matthew H. Slawson
Rankless by CCL
2026